The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility
Katarzyna Niebudek, Ewa Balcerczak, Marek Mirowski, Jacek Pietrzak, Izabela Zawadzka, Marta Żebrowska-Nawrocka Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Interfaculty Cathedral of Laboratory and Molecular Diagnostic...
Main Authors: | Niebudek K, Balcerczak E, Mirowski M, Pietrzak J, Zawadzka I, Żebrowska-Nawrocka M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-contribution-of-abcg2-g34a-and-c421a-polymorphisms-to-multiple-mye-peer-reviewed-article-OTT |
Similar Items
-
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
by: Cleophas MC, et al.
Published: (2017-04-01) -
Expression of ABCG2 (BCRP) in mouse models with enhanced erythropoiesis
by: Gladys Oluyemisi Latunde-Dada, et al.
Published: (2014-06-01) -
Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
by: Dorte Lisbet Nielsen, et al.
Published: (2017-09-01) -
Association of ABCB1 T-129C polymorphism and multiple myeloma risk in Polish population
by: Katarzyna Niebudek, et al.
Published: (2019-01-01) -
ABCG2 Overexpression Contributes to Pevonedistat Resistance
by: Rishil J. Kathawala, et al.
Published: (2020-02-01)